Synapse - Hematologic Malignancies Research

Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PMN/RAR-α isoform, and CD13 expression in patients treated with all-trans retinoic acid

Journal Article

Vahdat, L.; Maslak, P.; Miller, W. H. Jr; Eardley, A.; Heller, G.; Scheinberg, D. A.; Warrell, R. P. Jr
Blood (1994)

Fulltext@MSK | Save

A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: Specific targeting without immunogenicity

Journal Article

Caron, P. C.; Jurcic, J. G.; Scott, A. M.; Finn, R. D.; Divgi, C. R.; Graham, M. C.; Jureidini, I. M.; Sgouros, G.; Tyson, D.; Old, L. J.; more...
Blood (1994)

Fulltext@MSK | Save

Clinical implementation of modeling-based radioimmunotherapy treatment planning: I-131-M195 antibody against chronic myelogenous leukemia

Meeting Abstract

Sgouros, G.; Graham, M. C.; Scott, A.; Caron, P. C.; Divgi, C. R.; Finn, R.; Carabasi, M.; Larson, S. M.; Scheinberg, D. A.
Journal of Nuclear Medicine (1993)

Fulltext@MSK | Save

I-131 M195 (anti-CD33) radioimmunotherapy trials in patients with myeloid leukemias

Meeting Abstract

Larson, S. M.; Scott, A. M.; Divgi, C. R.; Finn, R. D.; Graham, M. C.; Sgouros, G.; Scheinberg, D. A.
Journal of Nuclear Medicine (1993)

Fulltext@MSK | Save

(131)I-labeled anti-CD33 ((131)I-M195) may prolong disease-free survival (DFS) in relapsed acute promyelocytic leukemia (APL) after remission induction with all-trans retinoic acid (RA)

Meeting Abstract

Jurcic, J. G.; Caron, P. C.; Miller, W. H. Jr; Yao, T. J.; Maslak, P.; Finn, R.; Larson, S. M.; Warrell, R. P. Jr; Scheinberg, D. A.
Blood (1993)

Fulltext@MSK | Save

Combination of biologic agents with chemotherapy limits toxicity in the treatment of elderly patients with AML

Meeting Abstract

Maslak, P.; Weiss, M.; Nichols, G.; Tyson, D.; Gee, T.; Berman, E.; Scheinberg, D.
Blood (1993)

Fulltext@MSK | Save